This may explain why, while MMP-3 levels in SF of rheumatoid arthritis (RA) patients are extremely high [3,9], depletion of MMP-3 in animal models does not prevent cleavage of aggrecan, nor does it prevent or reduce cartilage destruction observed in specific forms of arthritis [10-12]. This evidence concerns the gene ACAN and rheumatoid arthritis.